PRELIMINARYNOTICE is hereby given that the Second Annual General Meeting of the Members of the Company will be held at 8.00pm at the Crowne Plaza Hotel, Shaw’s Bridge, 117 Milltown Road Belfast BT8 7XP, on Thursday 23rd June 2022 for the purpose of considering the following business:
1. Notice of meeting.
2. Apologies for absence.
3. Directors’ Report on Company Activity in 2021.
4. Chairman’s Report.
5. Notice of Special Motion
Members will be asked to consider the Notice of Special Motion available HERE at the AGM that proposes changes to the constitution of the Board of CPNI, following the completion of the 3-year period of membership of CPNI Board by the UCA-nominated Directors.
6. Report on the Summary Income Statement and Balance Sheet for the year ended 31 October 2020.
7. Appointment of Auditors.
8. Appointment of Solicitors.
9. Closing remarks by the Chairman.
AGM papers will be sent out by post w/c 13th June 2022.
Any member wishing to submit a Notice of Motion should complete the Notice of Motion pro-form HERE and ensure it is returned to CPNI offices no later than Friday 10th June 2022.
By order of the Board
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
The Community Vaccination Service Update was issued on 31 May 2022 and is available on the hscni primary care portal. A PDF copy of the update is available for your convenience here.
The Governance section of the update includes important updated information on the extensions to manufacturer expiry dates and post-thaw expiry dates for applicable batches of Moderna Spikevax® vaccines, and includes a letter issued by PHA to GPs with a worked example.
Summary:
Update M3 issued on 1st February 2022 outlines the extension of the post-thaw expiry date for specific batches of Moderna Spikevax.
Review the attached correspondence and discuss with your pharmacy teams.
Identify any stocks of Moderna Spikevax vaccine which require revision of the manufacturer’s expiry and annotate the vial and packaging accordingly.
Identify any stocks of Moderna Spikevax vaccine which require revision of the post-thaw expiry (on the label affixed by Movianto) and annotate the label accordingly.
Review the worked examples in the PHA letter for guidance on the steps to follow when determining the revised expiry date of current stocks.
Should you have any queries please do not hesitate to speak to a member of the team.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
Please find attached correspondence HERE from Aidan Dawson, CEO of the Public Health Agency. The correspondence provides an update on the COVID-19 Spring Booster Vaccination Programme for Care Home Residents.
Summary:
The contribution of pharmacies involved in delivering the COVID-19 spring booster vaccination programme to care home residents is acknowledged.
Thanks are extended for the role played by pharmacy in ensuring over 10,000 residents have been vaccinated so far.
The original end date for the programme was 31 May 2022 but has now been extended to 15 June 2022 to allow further time for pharmacies, if they wish, to continue to vaccinate eligible care home residents, where appropriate.
Those pharmacies involved in the Spring Booster Care Home Vaccination programme are asked to support this final opportunity to ensure that this vulnerable group are vaccinated in this time.
Action:
Review the attached correspondence and discuss with your pharmacy teams.
If you wish to proceed to vaccinate care home residents into June, please make the necessary arrangements with the home.
If you are unable to extend the programme, please advise the care home accordingly so that Trust teams can implement plans to offer vaccinations to residents who previously missed your clinics.
The Community Vaccination Service Update also issued on 31 May 2022 and is available here.
Should you have any queries please do not hesitate to speak to a member of the team.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
The final update of concessionary prices were granted today for May 2022:
Drug
Pack Size
Concessionary Price
Aciclovir 400mg tablets
56
£3.20
Aciclovir 800mg tablets
35
£3.21
Aripiprazole 10mg tablets
28
£1.32
Benzydamine 0.15% oromucosal spray sugar free
30
£2.95
Bisacodyl 10mg suppositories
12
£2.77
Chlorpromazine 50mg tablets
28
£10.51
Clonidine 25microgram tablets
112
£11.50
Co-dydramol 10mg/500mg tablets
30
£2.29
Co-dydramol 10mg/500mg tablets
100
£7.63
Cyclizine 50mg/1ml solution for injection ampoules
Living well social media assets and schedule to support Know Check Ask campaign are now available at Social Media schedule (hscni.net).
As part of your Living Well resources, you will have received a Know Check Ask window sticker that was not referenced in previous SPPG correspondence. This is an additional resource, however it is not a replacement for display of the posters and as per your Living Well contract, posters must be displayed in at least one window unit of the pharmacy premises for the full duration of the campaign.
Serious Shortage Protocols (SSPs) May 2022 Update
To support contractors in managing the current SSPs arrangements, CPNI have produced a Serious Shortage Protocols (SSPs) May Update which can be found HERE.
Please bring this to the attention of your pharmacy team(s).
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Contractor
Please find attached correspondence HERE from Professor Sir Michael McBride, Chief Medical Officer; Ms Maria McIlgorm, Chief Nursing Officer and Mrs Cathy Harrison, Chief Pharmaceutical Officer.
SUMMARY
The eligibility criteria for COVID-19 Spring Booster Vaccination has been extended by one month and therefore those who will turn 75 years old by 30 June 2022 (i.e. those born before 30 June 1947), can receive a spring booster dose.
Any patient who turns 75 during June and requests vaccination, can receive their vaccine via a participating community pharmacy.
Contractors should contact their local SPPG office in the first instance should further information be required.
Please do not hesitate to contact CPNI office should you require any further information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
